REDPHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
REDPHARMA
Largest movements
- Receivables within one year +€3.0m
up €3.0m (+133.5%), from €2.2m to €5.2m
- Cash -€2.3m
down €2.3m (-67.2%), from €3.3m to €1.1m
mainly Receivables within one year (-€3.0m) and Contributions, distributions and other (-€2.0m)
- Deferred charges and accrued income -€76,445
down €76,445 (-95.0%), from €80,500 to €4,055
- Other debts +€232,966
up €232,966 (+11.6%), from €2.0m to €2.2m
- Profit (loss) carried forward +€192,032
up €192,032 (+18.7%), from €1.0m to €1.2m
- Accrued charges and deferred income +€158,923
up €158,923 (+139.9%), from €113,611 to €272,534
- Tax, wage and social debts +€83,186
up €83,186 (+7.9%), from €1.1m to €1.1m
of which Taxes: +€262,830
- Financial charges -€1.0m
down €1.0m (-96.5%), from €1.1m to €38,150
of which Non-recurring financial charges: -€1.0m
- Gross operating margin -€319,668
down €319,668 (-5.5%), from €5.9m to €5.5m
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €5,834,807 | €6,486,932 | +€652,125 | +11.2% |
| Fixed assets | 21/28 | €156,981 | €136,227 | -€20,754 | -13.2% |
| Intangible fixed assets | 21 | €48,569 | €35,910 | -€12,659 | -26.1% |
| Tangible fixed assets | 22/27 | €108,412 | €100,317 | -€8,095 | -7.5% |
| Furniture and vehicles | 24 | €108,412 | €100,317 | -€8,095 | -7.5% |
| Current assets | 29/58 | €5,677,826 | €6,350,705 | +€672,878 | +11.9% |
| Amounts receivable within one year | 40/41 | €2,248,000 | €5,249,476 | +€3.0m | +133.5% |
| Trade receivables | 40 | €2,248,000 | €5,249,476 | +€3.0m | +133.5% |
| Cash at bank and in hand | 54/58 | €3,349,326 | €1,097,174 | -€2.3m | -67.2% |
| Deferred charges and accrued income | 490/1 | €80,500 | €4,055 | -€76,445 | -95.0% |
| Total equity and liabilities | 10/49 | €5,834,807 | €6,486,932 | +€652,125 | +11.2% |
| Equity | 10/15 | €1,166,053 | €1,358,085 | +€192,032 | +16.5% |
| Contributions | 10/11 | €93,600 | €93,600 | = | 0.0% |
| Capital | 10 | €93,600 | €93,600 | = | 0.0% |
| Issued capital | 100 | €93,600 | €93,600 | = | 0.0% |
| Reserves | 13 | €45,342 | €45,342 | = | 0.0% |
| Non-distributable reserves | 130/1 | €9,360 | €9,360 | = | 0.0% |
| Legal reserve | 130 | €9,360 | €9,360 | = | 0.0% |
| Distributable reserves | 133 | €35,982 | €35,982 | = | 0.0% |
| Profit (loss) carried forward | 14 | €1,027,111 | €1,219,143 | +€192,032 | +18.7% |
| Amounts payable | 17/49 | €4,668,754 | €5,128,847 | +€460,093 | +9.9% |
| Amounts payable within one year | 42/48 | €4,555,143 | €4,856,313 | +€301,169 | +6.6% |
| Current portion of amounts payable after more than one year | 42 | €393,238 | €352,750 | -€40,488 | -10.3% |
| Trade debts | 44 | €1,111,829 | €1,137,334 | +€25,505 | +2.3% |
| Suppliers | 440/4 | €1,111,829 | €1,137,334 | +€25,505 | +2.3% |
| Taxes, remuneration and social security | 45 | €1,050,076 | €1,133,263 | +€83,186 | +7.9% |
| Taxes | 450/3 | €431,832 | €694,663 | +€262,830 | +60.9% |
| Remuneration and social security | 454/9 | €618,244 | €438,600 | -€179,644 | -29.1% |
| Other amounts payable | 47/48 | €2,000,000 | €2,232,966 | +€232,966 | +11.6% |
| Accrued charges and deferred income | 492/3 | €113,611 | €272,534 | +€158,923 | +139.9% |
| Non-recurring operating income | 76A | €1,026 | - | -€1,026 | |
| Remuneration, social security and pensions | 62 | €2,538,850 | €2,567,194 | +€28,345 | +1.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €41,142 | €41,720 | +€578 | +1.4% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | -€2,420 | -€6,175 | -€3,755 | -155.2% |
| Other operating charges | 640/8 | €76,716 | €23,961 | -€52,755 | -68.8% |
| Gross operating margin | 9900 | €5,854,864 | €5,535,196 | -€319,668 | -5.5% |
| Operating profit (loss) | 9901 | €3,200,577 | €2,908,497 | -€292,080 | -9.1% |
| Financial income | 75/76B | €129,372 | €81,156 | -€48,217 | -37.3% |
| Recurring financial income | 75 | €129,372 | €81,156 | -€48,217 | -37.3% |
| Financial charges | 65/66B | €1,086,890 | €38,150 | -€1.0m | -96.5% |
| Recurring financial charges | 65 | €40,110 | €38,150 | -€1,960 | -4.9% |
| Non-recurring financial charges | 66B | €1,046,780 | - | -€1.0m | |
| Profit (loss) for the period before taxes | 9903 | €2,243,059 | €2,951,502 | +€708,443 | +31.6% |
| Income taxes | 67/77 | €749,724 | €759,470 | +€9,747 | +1.3% |
| Profit (loss) for the period | 9904 | €1,493,335 | €2,192,032 | +€698,697 | +46.8% |
| Profit (loss) for the period to be appropriated | 9905 | €1,493,335 | €2,192,032 | +€698,697 | +46.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.